Copyright
©The Author(s) 2021.
World J Gastrointest Surg. May 27, 2021; 13(5): 392-405
Published online May 27, 2021. doi: 10.4240/wjgs.v13.i5.392
Published online May 27, 2021. doi: 10.4240/wjgs.v13.i5.392
Reference | Criteria | Definition | OS | Recurrence |
Mazzaferro et al[22] | Milan criteria | Solitary tumor ≤ 5 cm or total ≤ 3 tumors and each tumor ≤ 3 cm | 4-yr 75% | 4-yr RFS 83% |
Yao et al[24] | UCSF criteria | Solitary tumor ≤ 6.5 cm or total ≤ 3 nodules with the largest lesion ≤ 4.5 cm and total tumor diameter ≤ 8 cm | 5-yr 75.2% | 5-yr RR: 17% |
Takada et al[27] | Kyoto criteria | Tumor number ≤ 10 and maximal diameter of each tumor ≤ 5 cm and serum des-gamma-carboxy prothrombin levels ≤ 400 mAU/mL | 5-yr 87% | 5-yr RR: 5% |
Mazzaferro et al[26] | Up-to-Seven criteria | Sum of number of tumors ≤ 7 and maximal size of the largest tumor ≤ 7cm | 5-yr 71.2% | 5-yr RR: 9.1% |
- Citation: Panayotova G, Lunsford KE, Latt NL, Paterno F, Guarrera JV, Pyrsopoulos N. Expanding indications for liver transplantation in the era of liver transplant oncology. World J Gastrointest Surg 2021; 13(5): 392-405
- URL: https://www.wjgnet.com/1948-9366/full/v13/i5/392.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i5.392